GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd (SHSE:600329) » Definitions » Days Payable

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Days Payable : 101.39 (As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Tianjin Pharmaceutical Da Ren Tang Group Days Payable?

Tianjin Pharmaceutical Da Ren Tang Group's average Accounts Payable for the three months ended in Mar. 2024 was ¥1,123 Mil. Tianjin Pharmaceutical Da Ren Tang Group's Cost of Goods Sold for the three months ended in Mar. 2024 was ¥1,011 Mil. Hence, Tianjin Pharmaceutical Da Ren Tang Group's Days Payable for the three months ended in Mar. 2024 was 101.39.

The historical rank and industry rank for Tianjin Pharmaceutical Da Ren Tang Group's Days Payable or its related term are showing as below:

SHSE:600329' s Days Payable Range Over the Past 10 Years
Min: 53.69   Med: 67.78   Max: 100.36
Current: 91.64

During the past 13 years, Tianjin Pharmaceutical Da Ren Tang Group's highest Days Payable was 100.36. The lowest was 53.69. And the median was 67.78.

SHSE:600329's Days Payable is ranked better than
53.03% of 975 companies
in the Drug Manufacturers industry
Industry Median: 87.13 vs SHSE:600329: 91.64

Tianjin Pharmaceutical Da Ren Tang Group's Days Payable declined from Mar. 2023 (111.10) to Mar. 2024 (101.39). It may suggest that Tianjin Pharmaceutical Da Ren Tang Group accelerated paying its suppliers.


Tianjin Pharmaceutical Da Ren Tang Group Days Payable Historical Data

The historical data trend for Tianjin Pharmaceutical Da Ren Tang Group's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianjin Pharmaceutical Da Ren Tang Group Days Payable Chart

Tianjin Pharmaceutical Da Ren Tang Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 57.15 71.09 94.31 97.53 100.36

Tianjin Pharmaceutical Da Ren Tang Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 111.10 102.81 95.37 69.07 101.39

Competitive Comparison of Tianjin Pharmaceutical Da Ren Tang Group's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Tianjin Pharmaceutical Da Ren Tang Group's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tianjin Pharmaceutical Da Ren Tang Group's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tianjin Pharmaceutical Da Ren Tang Group's Days Payable distribution charts can be found below:

* The bar in red indicates where Tianjin Pharmaceutical Da Ren Tang Group's Days Payable falls into.



Tianjin Pharmaceutical Da Ren Tang Group Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Tianjin Pharmaceutical Da Ren Tang Group's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

Days Payable (A: Dec. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2022 ) + Accounts Payable (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (1405.89 + 1126.091) / 2 ) / 4604.084*365
=1265.9905 / 4604.084*365
=100.36

Tianjin Pharmaceutical Da Ren Tang Group's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

Days Payable (Q: Mar. 2024 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2023 ) + Accounts Payable (Q: Mar. 2024 )) / count ) / Cost of Goods Sold (Q: Mar. 2024 )*Days in Period
=( (1126.091 + 1119.735) / 2 ) / 1010.616*365 / 4
=1122.913 / 1010.616*365 / 4
=101.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tianjin Pharmaceutical Da Ren Tang Group Days Payable Related Terms

Thank you for viewing the detailed overview of Tianjin Pharmaceutical Da Ren Tang Group's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Business Description

Traded in Other Exchanges
Address
No. 17 Baidi Road, Zhong Xin Mansion, Nankai District, Tianjin, CHN, 300193
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is a pharmaceutical manufacturing company. The company manufactures and sells traditional Chinese medicine, western medicine, and healthcare products in the People's Republic of China. It operates in two segments namely The Chinese Medicine segment and The Western Medicine segment. The Chinese Medicine segment manufactures Chinese pharmaceutical products under brands owned by the group. The Western Medicine segment manufactures western pharmaceutical products through cooperation with foreign companies. The company earns the majority of its revenue from the sale of Chinese pharmaceutical products.

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Headlines

No Headlines